Literature DB >> 29296698

Hemoglobin variants identified in the Uganda Sickle Surveillance Study.

Beverly A Schaefer1, Charles Kiyaga2, Thad A Howard1, Grace Ndeezi3, Arielle G Hernandez1, Isaac Ssewanyana2, Mary C Paniagua4, Christopher M Ndugwa3, Jane R Aceng5, Russell E Ware1.   

Abstract

The Uganda Sickle Surveillance Study analyzed dried blood spots that were collected from almost 100 000 infants and young children from all 10 regions and 112 districts in the Republic of Uganda, with the primary objective of determining the prevalence of sickle cell trait and disease. An overall prevalence of 13.3% sickle cell trait and 0.7% sickle cell disease was recently reported. The isoelectric focusing electrophoresis technique coincidentally revealed numerous hemoglobin (Hb) variants (defined as an electrophoresis band that was not Hb A, Hb F, Hb S, or Hb C) with an overall country-wide prevalence of 0.5%, but with considerable geographic variability, being highest in the northwest regions and districts. To elucidate these Hb variants, the original isoelectric focusing (IEF) gels were reviewed to identify and locate the variant samples; corresponding dried blood spots were retrieved for further testing. Subsequent DNA-based investigation of 5 predominant isoelectric focusing patterns identified 2 α-globin variants (Hb Stanleyville II, Asn78Lys; Hb G-Pest, Asp74Asn), 1 β-globin variant (Hb O-Arab, Glu121Lys), and 2 fusion globin variants (Hb P-Nilotic, β31-δ50; Hb Kenya, Aγ81Leu-β86Ala). Compound heterozygotes containing an Hb variant plus Hb S were also identified, including both Hb S/O-Arab and HbS/Kenya. Regional differences in the types and prevalence of these hemoglobin variants likely reflect tribal ancestries and migration patterns. Algorithms are proposed to characterize these Hb variants, which will be helpful for emerging neonatal hemoglobinopathy screening programs that are under way in sub-Saharan Africa.

Entities:  

Year:  2016        PMID: 29296698      PMCID: PMC5744056          DOI: 10.1182/bloodadvances.2016000950

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  37 in total

1.  Haemoglobin Stanleyville II modifies sickle disease phenotype.

Authors:  Genia Burchall; Ellen Maxwell
Journal:  Pathology       Date:  2010-04       Impact factor: 5.306

2.  Homozygous haemoglobin O disease and conjugated hyperbilirubinaemia in a Sudanese family.

Authors:  S A Ibrahim; D Mustafa; A O Mohamed; M B Mohed
Journal:  BMJ       Date:  1992-01-04

3.  Rapid analysis of hemoglobin variants by cation-exchange HPLC.

Authors:  C N Ou; C L Rognerud
Journal:  Clin Chem       Date:  1993-05       Impact factor: 8.327

4.  Compound heterozygosity for Hb S and the hybrid HbS Lepore, P-Nilotic, and Kenya; comparison of hematological and hemoglobin composition data.

Authors:  T H Huisman
Journal:  Hemoglobin       Date:  1997-05       Impact factor: 0.849

5.  Clinical and hematological features of homozygous hemoglobin O-Arab [beta 121 Glu → Lys].

Authors:  Sayar Dror
Journal:  Pediatr Blood Cancer       Date:  2012-11-28       Impact factor: 3.167

6.  Some blood genetic markers of the Nuba and Hawazma tribes of western Sudan.

Authors:  R A Bayoumi; N Saha
Journal:  Am J Phys Anthropol       Date:  1987-07       Impact factor: 2.868

7.  Hb P-Nilotic or alpha 2(beta delta)2 in a Turkish family.

Authors:  C Altay; A Kutlar; J B Wilson; B B Webber; T H Huisman
Journal:  Hemoglobin       Date:  1987       Impact factor: 0.849

8.  Multiple alpha chain loci for human haemoglobins: Hb J-Buda and Hb G-Pest.

Authors:  S R Hollán; J G Szelenyi; G Brimhall; M Duerst; R T Jones; R D Koler; Z Stocklen
Journal:  Nature       Date:  1972-01-07       Impact factor: 49.962

9.  Detection of haemoglobinopathies at birth in Togo.

Authors:  M L North; M C Piffaut; I Duwig; A G Locoh-Donou; A M Locoh-Donou
Journal:  Nouv Rev Fr Hematol       Date:  1988

10.  Clinical course and molecular characterization of a compound heterozygote for sickle hemoglobin and hemoglobin Kenya.

Authors:  J S Waye; S P Cai; B Eng; D H Chui; W H Francombe
Journal:  Am J Hematol       Date:  1992-12       Impact factor: 10.047

View more
  2 in total

1.  Surveillance for sickle cell disease, United Republic of Tanzania.

Authors:  Emmanuela E Ambrose; Luke R Smart; Mwesige Charles; Arielle G Hernandez; Teresa Latham; Adolfine Hokororo; Medard Beyanga; Thad A Howard; Erasmus Kamugisha; Kathryn E McElhinney; Erius Tebuka; Russell E Ware
Journal:  Bull World Health Organ       Date:  2020-09-28       Impact factor: 13.831

2.  Protocol for "Genetic composition of sickle cell disease in the Arab population: A systematic review".

Authors:  Fateen Ata; Zohaib Yousaf; Sundus Sardar; Saad Javed; Phool Iqbal; Ibraheem Khamees; Lujain Salahaldeen Malkawi; Mohamed A Yassin
Journal:  Health Sci Rep       Date:  2022-05-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.